BRISTOL MYERS SQUIBB CO - 8-K Filing
Bristol-Myers Squibb held its annual meeting on May 5, 2026, where shareholders elected all 11 director nominees and approved management proposals related to executive compensation and the 2026 stock award plan. The advisory vote for executive compensation received 94.8% support (1,459 million votes), while the shareholder proposal on board chair independence was rejected with only 27.3% in favor. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $BMY